Data as of 3:59pm ET
| -0.08 / -0.64%|
NanoString Technologies, Inc. develops, manufactures and sells robust, intuitive products that unlock scientifically valuable and clinically actionable genomic information from minute amounts of tissue. Its nCounter Analysis System directly profiles hundreds of molecules simultaneously using a novel barcoding technology that is powerful enough for use in research, simple enough for use in clinical laboratories worldwide. The company operates its business through two Segments: Life Sciences and Diagnostics. The Life Sciences segment provides instruments, consumables and services for efficiently profiling the activity of hundreds of genes from a single tissue sample. The Diagnostics segment provides molecular diagnostic kits to pathology labs enabling complex molecular testing on a decentralized basis. NanoString Technologies was founded by Amber Ratcliffe, Krassen Dimitrov and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.
|Robert Bradley Gray||President, Chief Executive Officer & Director|
|Wayne D. Burns||Senior Vice President-Operations & Administration|
|James Algot Johnson||Chief Financial Officer|
|John Wayne Cowens||Chief Medical Officer|
|Joseph M. Beechem||Senior Vice President-Research & Development|